SCHEMBL5472002

SCHEMBL5472002

CCCCCCCCCCCCCCCCCCCCCCOC(=O)C1=COCCC1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
TSHR P16473 2/20 0.48
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAPK1 P28482 1/20 0.45
ESR1 P03372 4/20 0.44
NPC1 O15118 1/20 0.44
MAPT P10636 1/20 0.44
RAB9A P51151 1/20 0.44
AKR1C4 P17516 1/20 0.44
AKR1C3 P42330 1/20 0.44
AKR1C2 P52895 1/20 0.44
AKR1C1 Q04828 1/20 0.44
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17824534 0.81 TSHR (0.35) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL10620678 0.78 ALDH1A1 (0.51) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL1185177 0.77 ALDH1A1 (0.50) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL810728 0.77 ALDH1A1 (0.50) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL5604103 0.77 ALDH1A1 (0.50) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL20994214 0.76 TSHR (0.50) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL1976767 0.75 ALDH1A1 (0.49) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL17010721 0.75 ALDH1A1 (0.56) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL5073738 0.75 ALDH1A1 (0.56) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL6833278 0.73 TSHR (0.51) ALDH1A1TSHRLMNATP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2861706-B1 FABRIC CONDITIONING COMPOSITION AND USE THEREOF RHODIA OPERATIONS (FR) 2017-12-06 EP disclosed
US-20150197708-A1 Fabric Conditioning Composition And Use Thereof RHODIA OPERATIONS (FR) 2015-07-16 US disclosed
EP-2861706-A1 FABRIC CONDITIONING COMPOSITION AND USE THEREOF Rhodia Operations (FR) 2015-04-22 EP disclosed
US-8821845-B2 Concentrated ingredient for treating and/or modifying surfaces, and use thereof in cosmetic compositions RHODIA CHIMIE (FR) 2014-09-02 US disclosed
WO-2013189010-A1 FABRIC CONDITIONING COMPOSITION AND USE THEREOF RHODIA OPERATIONS (FR) 2013-12-27 WO disclosed
US-20070148116-A1 Concentrated ingredient for treating and/or modifying surfaces, and use thereof in cosmetic compositions RHODIA CHIMIE (FR) 2007-06-28 US disclosed
US-20060211594-A1 Composition based on nanoparticles or a nanolatex of polymers for fabric care RHODIA CHIMIE 2006-09-21 US disclosed
US-20060194711-A1 Preformulated additive for a composition for treating textile fiber articles and use of said additive as care agent PROCTER & GAMBLE COMPAMY, THE 2006-08-31 US disclosed
US-7094747-B2 Process for cleaning a surface using an aqueous composition containing a dispersed polymer RHODIA CHIMIE (FR) 2006-08-22 US disclosed
US-7071156-B2 Composition based on nanoparticles or a nanolatex of polymers for fabric care RHODIA CHIMIE (FR) 2006-07-04 US disclosed
US-20040038851-A1 Use, in formulation for treating fabrics in an aqueous or wet medium, of nanoparticles made of at least one polymer which is insoluble under the working conditions,as crease-resistance agent and/or agent for helping in ironing PROCTER & GAMBLE COMPAMY, THE 2004-02-26 US disclosed
US-20030109413-A1 Process for cleaning a surface using an aqueous composition containing a dispersed polymer PROCTER & GAMBLE COMPAY, THE 2003-06-12 US disclosed
US-20030050218-A1 Preformulated additive for a composition for treating textile fiber articles and use of said additive as care agent PROCTER & GAMBLE COMPAMY, THE 2003-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070148116-A1 Concentrated ingredient for treating and/or modifying surfaces, and use thereof in cosmetic compositions PLOD3, CUTA, PLOD2 ALDH1A1 676/4885TSHR 4267/4885LMNA 1253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.